title: Angiotensin II-induced Ca(2+)-oscillations in vascular myocytes from the rat pulmonary artery.
abstract: The effect of angiotensin II (ANG II) on the cytosolic calcium concentration ([Ca2+]i) was studied in freshly (2-8 h) isolated myocytes from the main pulmonary artery of the rat. Myocytes were loaded with the fluorescent indicator indo 1 (1 microM for 30 min) and experiments were performed at room temperature. Short (30 s) applications of ANG II (0.01-10 microM) induced cyclic variations oscillations in [Ca2+]i. The ANG II-induced response was typically composed of three to six oscillations of constant duration (9.8 +/- 0.5 s, n = 40) but of decreasing amplitude. The first oscillation increased [Ca2+]i from 119 +/- 4 to 884 +/- 33 nM (n = 32). ANG II-induced response was concentration dependently inhibited by previous addition to the bathing solution of losartan or SR-47436 (0.01-0.1 microM, each), two specific AT1 receptor-antagonists. In Ca(2+)-free external solutions (containing 0.4-1 mM EGTA), ANG II still produced oscillation in [Ca2+]i. These oscillations disappeared in myocytes pretreated with neomycin (0.1 microM), thapsigargin (1 microM), or phorbol 12,13-dibutyrate (PDBu, 1 microM). In contrast to ANG II, caffeine (o.5-10 mM) induced only one transient rise in [Ca2+]i, which was unaltered by neomycin or PDBu but blocked by thapsigargin. These results show that ANG II produces oscillations in [Ca2+]i in pulmonary arterial myocytes via stimulation of AT1 receptors coupled to phospholipase C activation. ANG II-induced oscillations appear to be related to the cycling of Ca2+ ions from an intracellular store (presumably the sarcoplasmic reticulum) by a primarily inositol trisphosphate-dependent Ca2+ release.
authors.affiliation: Laboratoire de Physiologie, Université Bordeaux 2, France.
authors.forename: C
authors.initials: C
authors.lastname: Guibert
authors.forename: R
authors.initials: R
authors.lastname: Marthan
authors.forename: J P
authors.initials: JP
authors.lastname: Savineau
mesh_terms: D000804:Angiotensin II / Q000494:pharmacology*; D057911:Angiotensin Receptor Antagonists; D000818:Animals; D002110:Caffeine / Q000494:pharmacology; D002118:Calcium / Q000502:physiology*; D000252:Calcium-Transporting ATPases / Q000037:antagonists & inhibitors; D003600:Cytosol / Q000378:metabolism; D008297:Male; D009131:Muscle, Smooth, Vascular / Q000166:cytology / Q000502:physiology*; D009355:Neomycin / Q000494:pharmacology; D009991:Oscillometry; D009994:Osmolar Concentration; D015240:Phorbol 12,13-Dibutyrate / Q000494:pharmacology; D011651:Pulmonary Artery / Q000166:cytology / Q000502:physiology*; D051381:Rats; D017208:Rats, Wistar; D019284:Thapsigargin / Q000494:pharmacology
chemical_list: D057911:Angiotensin Receptor Antagonists; D000804:Angiotensin II; D015240:Phorbol 12,13-Dibutyrate; D002110:Caffeine; D019284:Thapsigargin; D000252:Calcium-Transporting ATPases; D009355:Neomycin; D002118:Calcium